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Perforating folliculitis and hand-foot-skin reaction due to sorafenib
Stephanie Chapman, MS, MD and Anna Axelson, MD Department of
Dermatology Henry Ford Health System, Detroit, Michigan
Case presentation

Discussion

Clinical Images

• A 62-year-old African American woman presented with a painful rash on the
extremities and feet ongoing for 2 months
• Her past medical history was as follows:
• Hepatitis C virus infection treated with harvoni in 2018
• Liver cirrhosis
• Hepatocellular carcinoma (HCC) diagnosed 7 months prior to
presentation, currently on sorafenib
• Painful rough, dark bumps erupted about 3 months after beginning treatment
for HCC with sorafenib 400 mg BID
• She also had painful, yellow calluses on the bilateral plantar feet that erupted
around the same time as the rash on the extremities

Physical Exam
• Scattered on the bilateral lower extremities and left upper extremity there
were many small hyperpigmented papules with central keratotic plug and
surrounding erythema (Figures 2 and 3)
• On the bilateral plantar feet there were thick hyperkeratotic, yellow and
hyperpigmented plaques overlying the calcaneus and metatarsal phalangeal
joints (Figure 4)

Figure 2. Hyperpigmented papules
with central keratotic plug on the
left leg

Figure 3. Close up of a keratotic
papule on the right hip that was
biopsied
Figure 4. Hyperkeratotic
yellow and
hyperpigmented plaques on
the bilateral plantar feet
overlying sites of pressure

• The bilateral palms exhibited ill-defined erythematous patches

Diagnostic workup
• CMP was within normal limits
• Skin biopsies from keratotic papules on the right hip and right leg
demonstrated a dilated hair follicle containing orthokeratotic and
parakeratotic keratin and basophilic debris, consistent with perforating
folliculitis (Figure 1)

Diagnosis and Treatment
• Her palmar and plantar exam was consistent with hand-foot-skin
reaction due to sorafenib
• She was started on clobetasol 0.05% ointment twice daily to the feet
with improvement
• For the perforating folliculitis due to sorafenib she was started on
doxycycline 100 mg BID and topical clobetasol 0.05% ointment BID
to all affected areas on the body without improvement
• For her HCC she was maintained on the full dose of sorafenib 400 mg
BID for 6 months before stopping and switching to nivolumab due to
progression of her liver disease

Figure 1: H&E demonstrating follicular plug and perforation

• She was not able to follow up with dermatology due to worsening of
her liver disease requiring hospitalization

• Sorafenib is an oral multikinase inhibitor approved for
the treatment of renal cell carcinoma, HCC, and thyroid
cancer
• Sorafenib and other multikinase inhibitors are known to
cause various adverse cutaneous reactions including
hand-foot-skin reaction, which is different from handfoot-skin syndrome, as well as inflammatory eruptions
and alopecia1
• Hand-foot-skin reaction is a painful complication
characterized by hyperkeratotic plaques that develop over
sites of pressure on the hands and feet, and are usually
bilateral and symmetric1
• Treatment of mild cases includes use of emollients,
keratolytic creams, and shoe inserts1
• Potent topical steroids may also be used, and severe
cases necessitate dose reduction of the targeted therapy
by at least 50%1
• Hand-foot-skin syndrome is a separate condition which
is under the broader category of toxic erythema of
chemotherapy, and is caused by a variety of
chemotherapeutic agents and manifests as welldemarcated erythema of the palms and soles with
edema and dysesthesia in severe cases
• Perforating folliculitis is a more rare complication of
sorafenib that has only been reported in a few case
reports2,3
• The pathogenesis is unknown
• Various treatments for perforating folliculitis have been
tried including topical retinoids, topical steroids, and
oral doxycycline with minimal efficacy2,3
• In one case, there was reported improvement with oral
isotretinoin after five months3
• Perforating folliculitis usually improves after treatment
cessation
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